Clinical Trial Update: Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating decitabine in combination with valproic acid for recurrent or stage IV non-small cell lung cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Dacogen (decitabine)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer | Phase 1 | Status: COMPLETED